CHO Pharma (ROCO:6586) Beginning Cash Position: NT$52.09 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6586 CHO Pharma Inc ROCO:6586
25 GF Score
Price NT$114.50
! 1 Warning Sign
View Full Analysis

What is CHO Pharma Beginning Cash Position?

CHO Pharma ROCO:6586 +0.88% 25 Beginning Cash Position is NT$52.09 Mil as of Jun. 2026. GuruFocus rates ROCO:6586 with a GF Score™ of 25/100. The stock has 1 warning sign investors should review.

CHO Pharma's Beginning Cash Position for the quarter that ended in Jun. 2026 was NT$52.09 Mil.

CHO Pharma's quarterly Beginning Cash Position increased from Jun. 2025 (NT$21.81 Mil) to Dec. 2025 (NT$168.87 Mil) but then declined from Dec. 2025 (NT$168.87 Mil) to Jun. 2026 (NT$52.09 Mil).

CHO Pharma's annual Beginning Cash Position declined from Dec. 2023 (NT$505.66 Mil) to Dec. 2024 (NT$203.79 Mil) and declined from Dec. 2024 (NT$203.79 Mil) to Dec. 2025 (NT$21.81 Mil).

CHO Pharma Beginning Cash Position Related Terms

CHO Pharma Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for CHO Pharma's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CHO Pharma Beginning Cash Position Chart

CHO Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 986.39 777.98 505.66 203.79 21.81

CHO Pharma Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 203.79 117.77 21.81 168.87 52.09
ROCO:6586
25GF Score
CHO Pharma Inc ROCO:6586
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CHO Pharma Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of NT$52.09 Mil mean?
CHO Pharma (ROCO:6586) has a Beginning Cash Position of NT$52.09 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on CHO Pharma and its competitors.
Is CHO Pharma's Beginning Cash Position too high?
CHO Pharma's current Beginning Cash Position is NT$52.09 Mil. Overall, CHO Pharma has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does CHO Pharma's Beginning Cash Position compare to VRTX and REGN?
CHO Pharma's Beginning Cash Position of NT$52.09 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on CHO Pharma and its competitors. CHO Pharma's current Beginning Cash Position is NT$52.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CHO Pharma stock overvalued right now?
CHO Pharma (ROCO:6586) has a current Beginning Cash Position of NT$52.09 Mil. The current Beginning Cash Position is NT$52.09 Mil. CHO Pharma's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For CHO Pharma (ROCO:6586), the current Beginning Cash Position is NT$52.09 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CHO Pharma Business Description

Address Lane 130, Sec. 1 Academia Road, 7th Floor, Building C, No.99, Nangang, Taipei, TWN, 115202
CHO Pharma Inc is a biopharmaceutical company mainly focused on the development and commercialization of innovative products based on the proprietary glycan engineering technologies. It offers antibodies, such as CHO-H01, CHO-H02, CHO-A04 for cancer; CHO-H03, an antibody for autoimmune disease; CHO-S05 dual-effect anti-flu drugs; and CHO-V06 glycan-based vaccines and drugs.
25GF Score

Get the complete analysis for ROCO:6586

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$114.50
Price